See What HealthDay Can Do For You
Contact Us

December 2009 Briefing - Nephrology

Here are what the editors at HealthDay consider to be the most important developments in Nephrology for December 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Declines Found in Diabetes-Related Renal Disease

WEDNESDAY, Dec. 30 (HealthDay News) -- Among individuals with diabetes, the incidence of diabetes-related end-stage renal disease (ESRD) declined in recent years, which suggests that efforts to prevent ESRD are successful, according to research published in the January issue of Diabetes Care.

Abstract
Full Text

Gadolinium-Based Contrast Agents Possibly Dangerous

WEDNESDAY, Dec. 30 (HealthDay News) -- In patients with renal function impairment, the use of gadolinium-based contrast agents is risky because it can lead to the development of nephrogenic systemic fibrosis, according to a study in the January issue of The Journal of Urology.

Abstract
Full Text (subscription or payment may be required)

Therapies for CAD Patients With Kidney Disease Compared

MONDAY, Dec. 28 (HealthDay News) -- Percutaneous coronary intervention (PCI) used with medical therapy or medical therapy used singly improved angina symptoms similarly among patients with coronary artery disease (CAD) and chronic kidney disease (CKD), according to a study in the Dec. 15 issue of the American Journal of Cardiology.

Abstract
Full Text (subscription or payment may be required)

Over 85s Function Well Despite Disease and Disability

WEDNESDAY, Dec. 23 (HealthDay News) -- Elders over the age of 85 report good health and functional ability despite the fact that they have to contend with a range of diseases and disabilities; however, as the fastest growing segment of the world's population, the health needs of future generations of over 85s represent a profound challenge, according to a study published online Dec. 22 in BMJ.

Abstract
Full Text
Editorial

Study Ties Ambulatory BP Monitoring to Disturbed Sleep

FRIDAY, Dec. 18 (HealthDay News) -- Ambulatory monitoring of blood pressure is associated with reduced sleep and physical activity, and may increase the likelihood that blood pressure will not follow normal circadian rhythms, according to a study published online Dec. 17 in the Clinical Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

Sudden Loss of Kidney Function May Up Risk of Death

FRIDAY, Dec. 18 (HealthDay News) -- Patients with a sudden loss of kidney function have a higher death rate after being discharged from the hospital even if their kidney function returned to normal, according to a study published online Dec. 17 in the Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

Chronic Kidney Patients Can Benefit From Carotid Surgery

MONDAY, Dec. 14 (HealthDay News) -- Patients with chronic kidney disease and high-grade carotid stenosis are at higher risk of stroke than those with preserved renal function, and they benefit more from carotid endarterectomy, according to a study published online Dec. 10 in the Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

Patients Often Lack Knowledge of Their Own Medications

THURSDAY, Dec. 10 (HealthDay News) -- Patients routinely under-report, or even over-report, their outpatient and inpatient medications, and should be included in hospital medication management to improve safety, according to a study published online Dec. 10 in the Journal of Hospital Medicine.

Abstract
Full Text (subscription or payment may be required)

Variable A1C Linked to Renal Disease in Type 1 Diabetes

THURSDAY, Dec. 10 (HealthDay News) -- In patients with type 1 diabetes, greater variability in A1C levels over time is associated with higher risk of microalbuminuria, progression of established renal disease, and cardiovascular disease (CVD) events, according to research published in the November issue of Diabetes.

Abstract
Full Text (subscription or payment may be required)

Quality Varies on Internet Urological Cancer Information

WEDNESDAY, Dec. 9 (HealthDay News) -- The quality of Web sites providing information about urological cancers may have improved in recent years, but many sites offer reason for concern, according to research published in the November issue of Urology.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Tool Helps Predict Mortality in Hemodialysis Patients

FRIDAY, Dec. 4 (HealthDay News) -- A new prognostic tool may help physicians give hemodialysis patients a six-month prognosis, according to a study published online Dec. 3 in the Clinical Journal of the American Society of Nephrology.

Abstract
Full Text (subscription or payment may be required)

Enzyme Therapy Brings Relief in Fabry's Disease

WEDNESDAY, Dec. 2 (HealthDay News) -- Patients with Fabry's disease improved their cardiac hypertrophy, reduced their pain, and improved their quality of life after five years of agalsidase alfa enzyme replacement therapy, according to a study published online Dec. 2 in The Lancet.

Abstract
Full Text (subscription or payment may be required)

Women Researchers Lag Behind Men in Grant Awards

TUESDAY, Dec. 1 (HealthDay News) -- Female physicians with a proven interest in research are less likely to receive prestigious research grants from the National Institutes of Health (NIH) than are male physicians, according to a study in the Dec. 1 issue of the Annals of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Physician's Briefing
undefined
undefinedundefined